2002
DOI: 10.2174/0929867023368890
|View full text |Cite
|
Sign up to set email alerts
|

HIV Protease Inhibitors: Peptidomimetic Drugs and Future Perspectives

Abstract: A literature review on the human immunodeficiency virus (HIV), the causative agent of acquired immune deficiency syndrome (AIDS). This review includes its life cycle, HIV protease structure, function, and substrates, as well as the mechanism and the design of inhibitors including the clinically approved drugs. Moreover the review mentioned the problems that hindered the development of peptidomimetic drug candidates as HIV protease inhibitors and the different approaches used by medicinal chemists to overcome t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
34
0

Year Published

2005
2005
2011
2011

Publication Types

Select...
3
2
2

Relationship

1
6

Authors

Journals

citations
Cited by 48 publications
(35 citation statements)
references
References 0 publications
1
34
0
Order By: Relevance
“…Consistent better performances of the holographic descriptors were gained with the HIVP and NK dataset. In the case of HIVP this might be a consequence of the comparably higher average molecular weight and peptidic nature of these inhibitors [23]. Multiple occurrences of substructure elements like the amide bond are accounted for by the holographic fingerprint but not by the binary fingerprint representation.…”
Section: Resultsmentioning
confidence: 99%
“…Consistent better performances of the holographic descriptors were gained with the HIVP and NK dataset. In the case of HIVP this might be a consequence of the comparably higher average molecular weight and peptidic nature of these inhibitors [23]. Multiple occurrences of substructure elements like the amide bond are accounted for by the holographic fingerprint but not by the binary fingerprint representation.…”
Section: Resultsmentioning
confidence: 99%
“…Each monomer contains a prominent β hairpin loop, known as the “flap,” that projects over the substrate-binding cleft. These flaps are highly flexible and can undergo large localized conformational changes upon substrate and inhibitor binding [25–27]. …”
Section: Hiv-1 Proteasementioning
confidence: 99%
“…The inhibitors function by creating a hydrogen bond network with a tetra-coordinated structural water molecule that is tightly bound between the inhibitor and the flaps. Inhibition is also depended upon critical interactions between the catalytic aspartates and the inhibitor [27]. …”
Section: Hiv-1 Proteasementioning
confidence: 99%
“…Hydroxyethylene (HE) is another important isostere of the aspartyl protease inhibitors and the HIV drug, Indina vir, which adopts it as a scaffold, was approved to go on the market several years ago [27] . Ghosh and co-workers have proven that compounds that incorporate substituted isopthalamides as P 2 -P 3 ligands in combination with the Leu-Ala HE dipeptide isostere can also form direct hydrogen bonds with the catalytic aspartates and display excellent potencies toward BACE-1; this group discovered the most potent compound, GRL-7234, described above [14] .…”
Section: Introductionmentioning
confidence: 99%